Black Diamond Therapeutics (BDTX) Non Operating Income (2019 - 2021)
Historic Non Operating Income for Black Diamond Therapeutics (BDTX) over the last 3 years, with Q4 2021 value amounting to -$375000.0.
- Black Diamond Therapeutics' Non Operating Income fell 16732.5% to -$375000.0 in Q4 2021 from the same period last year, while for Dec 2021 it was -$891000.0, marking a year-over-year decrease of 20022.5%. This contributed to the annual value of -$2.2 million for FY2021, which is 19447.32% down from last year.
- Per Black Diamond Therapeutics' latest filing, its Non Operating Income stood at -$375000.0 for Q4 2021, which was down 16732.5% from -$489000.0 recorded in Q3 2021.
- In the past 5 years, Black Diamond Therapeutics' Non Operating Income ranged from a high of $557000.0 in Q4 2020 and a low of -$5.3 million during Q2 2019
- Over the past 3 years, Black Diamond Therapeutics' median Non Operating Income value was -$489000.0 (recorded in 2021), while the average stood at -$774111.1.
- Per our database at Business Quant, Black Diamond Therapeutics' Non Operating Income surged by 10864.22% in 2020 and then tumbled by 22778.99% in 2021.
- Over the past 3 years, Black Diamond Therapeutics' Non Operating Income (Quarter) stood at $469000.0 in 2019, then increased by 18.76% to $557000.0 in 2020, then plummeted by 167.32% to -$375000.0 in 2021.
- Its Non Operating Income stands at -$375000.0 for Q4 2021, versus -$489000.0 for Q3 2021 and -$584000.0 for Q2 2021.